To help break the impasse with Sanofi (SNY), Genzyme (GENZ) is considering a deal structure in...

|About: Sanofi (SNY)|By:, SA News Editor

To help break the impasse with Sanofi (SNY), Genzyme (GENZ) is considering a deal structure in which shareholders would get a future payment based on the performance of Genzyme's Campath drug. Sanofi has signaled it's open to the idea, though sources say the main obstacle is still Sanofi's unwillingness to raise its offer.